Other Assets, Noncurrent of ImmunityBio, Inc. from 31 Dec 2014 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of noncurrent assets classified as other.
Summary
ImmunityBio, Inc. quarterly Other Assets, Noncurrent in USD history and change rate from 31 Dec 2014 to 31 Dec 2024.
  • ImmunityBio, Inc. Other Assets, Noncurrent for the quarter ending 31 Dec 2024 was $4,827,000, a 68% increase year-over-year.
Source SEC data
View on sec.gov
Other Assets, Noncurrent, Quarterly (USD)
Other Assets, Noncurrent, YoY Quarterly Change (%)

ImmunityBio, Inc. Quarterly Other Assets, Noncurrent (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $4,827,000 +$1,947,000 +68% 31 Dec 2024 10-K 03 Mar 2025 2024 FY
Q3 2024 $3,643,000 +$216,000 +6.3% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 $2,660,000 -$1,114,000 -30% 30 Jun 2024 10-Q 12 Aug 2024 2024 Q2
Q1 2024 $2,729,000 -$1,816,000 -40% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 $2,880,000 -$1,980,000 -41% 31 Dec 2023 10-K 03 Mar 2025 2024 FY
Q3 2023 $3,427,000 -$1,706,000 -33% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 $3,774,000 -$2,250,000 -37% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $4,545,000 -$1,932,000 -30% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $4,860,000 -$1,915,000 -28% 31 Dec 2022 10-K 19 Mar 2024 2023 FY
Q3 2022 $5,133,000 -$2,309,000 -31% 30 Sep 2022 10-Q 09 Nov 2022 2022 Q3
Q2 2022 $6,024,000 -$773,000 -11% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 $6,477,000 +$4,572,000 +240% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $6,775,000 +$4,177,000 +161% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $7,442,000 +$5,413,000 +267% 30 Sep 2021 10-Q 12 Nov 2021 2021 Q3
Q2 2021 $6,797,000 +$4,195,000 +161% 30 Jun 2021 10-Q 12 Aug 2021 2021 Q2
Q1 2021 $1,905,000 -$2,146,000 -53% 31 Mar 2021 10-Q 14 May 2021 2021 Q1
Q4 2020 $2,598,000 -$2,920,000 -53% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $2,029,000 -$1,255,000 -38% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $2,602,000 +$2,292,000 +739% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 $4,051,000 +$3,737,000 +1190% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $5,518,000 +$3,991,000 +261% 31 Dec 2019 8-K/A 22 Apr 2021
Q3 2019 $3,284,000 +$1,701,000 +107% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $310,000 -$44,000 -12% 30 Jun 2019 10-Q 06 Aug 2019 2019 Q2
Q1 2019 $314,000 -$52,000 -14% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $1,527,000 +$1,197,000 +363% 31 Dec 2018 10-K 25 Mar 2020 2019 FY
Q3 2018 $1,583,000 +$1,259,000 +389% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $354,000 +$19,000 +5.7% 30 Jun 2018 10-Q 06 Aug 2018 2018 Q2
Q1 2018 $366,000 -$295,000 -45% 31 Mar 2018 10-Q 07 May 2018 2018 Q1
Q4 2017 $330,000 -$458,000 -58% 31 Dec 2017 10-K 13 Mar 2019 2018 FY
Q3 2017 $324,000 -$538,000 -62% 30 Sep 2017 10-Q 07 Nov 2017 2017 Q3
Q2 2017 $335,000 -$805,000 -71% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 $661,000 -$1,035,000 -61% 31 Mar 2017 10-Q 08 May 2017 2017 Q1
Q4 2016 $788,000 -$571,000 -42% 31 Dec 2016 10-K 12 Mar 2018 2017 FY
Q3 2016 $862,000 -$464,000 -35% 30 Sep 2016 10-Q 10 Nov 2016 2016 Q3
Q2 2016 $1,140,000 -$2,617,000 -70% 30 Jun 2016 10-Q 15 Aug 2016 2016 Q2
Q1 2016 $1,696,000 31 Mar 2016 10-Q 16 May 2016 2016 Q1
Q4 2015 $1,359,000 +$950,000 +232% 31 Dec 2015 10-K 15 Mar 2017 2016 FY
Q3 2015 $1,326,000 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 $3,757,000 30 Jun 2015 10-Q 10 Sep 2015 2015 Q2
Q4 2014 $409,000 31 Dec 2014 10-K 30 Mar 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.